NCT06571773

Brief Summary

The objective of this study is to evaluate the postoperative visual quality and IOL stability in patients with cataracts and high myopia who have undergone surgery using astigmatism-correcting IOLs in conjunction with tension rings.It is a non-randomised retroprospective cohort study. Patients with high axial myopia (AL ≥ 26 mm) who underwent cataract phacoemulsification combined with toric IOL(Acrysof SN6ATY IQ toric IOL, Alcon, Alcon Laboratories, Fort Worth, Texas, USA) implantation from October 2020 to September 2023 at the Shanghai Tenth People's Hospital are selected. According to the usage of CTR, all patients will be divided into CTR group and control group, with a minimum follow-up of 3 months.Each patient underwent a comprehensive preoperative examination and ophthalmological examinations at the outpatient clinic 1 day, 1 week, 1 month, and 3 months postoperatively.Statistical analysis will be conducted using SPSS 26.0 statistical software.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 23, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 26, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2026

Completed
Last Updated

August 28, 2025

Status Verified

August 1, 2024

Enrollment Period

1.9 years

First QC Date

August 23, 2024

Last Update Submit

August 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative IOL rotation degree

    The surgeon, using the same slit lamp microscope and a narrow band of light, measured the IOL axial position after the patients' pupils were fully dilated with compound tropicamide eye drops

    3 months

Study Arms (2)

CTR group

This group include the patients with the usage of CTR

Procedure: intraoperative implantation of Capsular Tension Ring

control group

This group include the patients without the usage of CTR

Procedure: none intraoperative implantation of CTR

Interventions

The Capsular Tension Ring(ACPi-11; Bausch + Lomb, Rochester, New York, USA) is a device made of PMMA with blunt-tipped eyelets at its ends. It can be inserted at any point during cataract surgery, following the creation of a strong anterior capsulotomy via capsulorhexis

CTR group

the surgeon did a surgery without the intraoperative implantation of CTR

control group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Cataract ultrasonic emulsification aspiration with one-stage implantation of astigmatic IOL at the Shanghai Tenth People's Hospital from October 2020 to September 2023

You may qualify if:

  • Cataract ultrasonic emulsification aspiration with one-stage implantation of astigmatic IOL at the Shanghai Tenth People's Hospital from October 2020 to September 2023;
  • Ocular axial length ≥26.00mm;
  • Completion of outpatient follow up for more than 3 months.

You may not qualify if:

  • irregular corneal astigmatism, iris abnormalities, and pupil distortion;
  • history of previous corneal or intraocular surgery;
  • previous ocular diseases such as uveitis, retinopathy, macular degeneration, glaucoma, and keratoconus;
  • postoperative posterior capsule rupture, and suspensory ligament dissociation of greater than 1 quadrant;
  • corneal endothelial cell counts of less than 2000 cells/mm2.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai 10th People's Hospital

Shanghai, Shanghai Municipality, 200000, China

Location

MeSH Terms

Conditions

CataractAstigmatism

Condition Hierarchy (Ancestors)

Lens DiseasesEye DiseasesRefractive Errors

Study Officials

  • Yili Sun

    Shanghai 10th People's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Physician

Study Record Dates

First Submitted

August 23, 2024

First Posted

August 26, 2024

Study Start

January 1, 2024

Primary Completion

November 30, 2025

Study Completion

January 31, 2026

Last Updated

August 28, 2025

Record last verified: 2024-08

Locations